On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis
At #MJBizCon2019, Business of Cannabis joined MNP, MGO Ello, Aird + Berlis and the Canadian Securities Exchange inside their Canada’s Cannabis Scene booth to conduct conversations about
Jonathan Havens of Saul Ewing Arnstein & Lehr LLP to talk about what the US FDA’s approval of GW Pharma’s
We won’t spam you
